CN111012893A - Ginger extract with anti-inflammatory activity and preparation method thereof - Google Patents

Ginger extract with anti-inflammatory activity and preparation method thereof Download PDF

Info

Publication number
CN111012893A
CN111012893A CN202010017118.0A CN202010017118A CN111012893A CN 111012893 A CN111012893 A CN 111012893A CN 202010017118 A CN202010017118 A CN 202010017118A CN 111012893 A CN111012893 A CN 111012893A
Authority
CN
China
Prior art keywords
ginger
extracting
dried
extract
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010017118.0A
Other languages
Chinese (zh)
Inventor
郭孝萱
钱永忠
邱静
宿冬雪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Agricultural Quality Standards and Testing Technology for Agro Products of CAAS
Original Assignee
Institute of Agricultural Quality Standards and Testing Technology for Agro Products of CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Agricultural Quality Standards and Testing Technology for Agro Products of CAAS filed Critical Institute of Agricultural Quality Standards and Testing Technology for Agro Products of CAAS
Priority to CN202010017118.0A priority Critical patent/CN111012893A/en
Publication of CN111012893A publication Critical patent/CN111012893A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/17Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A ginger extract with anti-inflammatory activity and a preparation method thereof belong to the field of biological medicine. The method comprises the following steps: dried ginger powder heated to be completely dried at a temperature of 60 ℃ to 90 ℃ is provided. Extracting the dried ginger powder by using ethanol or ethanol with the volume content of more than 50% as an extracting agent at the material-liquid ratio of 1: 1-1: 40 and under the condition of normal temperature-90 ℃ to obtain an extracting solution. The rhizoma Zingiberis recens extract obtained by the method has high activity, and is suitable for anti-inflammatory application.

Description

Ginger extract with anti-inflammatory activity and preparation method thereof
Technical Field
The application relates to the field of biological pharmacy, in particular to a ginger extract with anti-inflammatory activity and a preparation method thereof.
Background
The anti-inflammatory activity of ginger as a plant used as both medicine and food is widely reported and applied. The anti-inflammatory activity of the ginger extract on an animal level and a cell level is researched by a plurality of scholars, and the result proves that the ginger extract can effectively reduce the secretion of inflammatory factors, the expression of inflammatory genes and the risk of inflammation-related diseases. Therefore, ginger or an extract thereof is taken as a main component in many anti-inflammatory related food formulas and functional foods at present. However, the extract obtained by the existing ginger extraction method has low activity, thereby limiting the application of the extract in the aspect of anti-inflammation.
Disclosure of Invention
The application provides a ginger extract and a preparation method thereof, which aim to solve the problem that the extract obtained by the existing ginger extraction method is not high in activity.
The application is realized as follows:
in a first aspect, examples of the present application provide a method of preparing a ginger extract.
The method comprises the following steps:
providing dry ginger powder obtained by heating fresh ginger to be dry at a temperature of 60-90 ℃, wherein the particle size of the dry ginger powder is below the aperture of a mesh of a 30-mesh screen.
Extracting the dried ginger powder for 3 to 5 times with the material-liquid ratio of 1:1g/mL to 1:40g/mL for 30 to 60 minutes each time by using ethanol or ethanol with the volume content of more than 50% as an extracting agent, and combining the extracting agents after three times of extraction to obtain an extracting solution. Removing ethanol from the extractive solution by distillation under reduced pressure, and freeze drying to obtain solid.
In a second aspect, embodiments of the present application provide a ginger extract obtained by the aforementioned method for preparing a ginger extract.
In the implementation process, the method provided by the embodiment of the application completely dries the ginger at the temperature of 60-90 ℃, so that the activity of the active substances in the ginger is improved, and then the active substances are extracted. The obtained ginger extract has anti-inflammatory effect.
Drawings
In order to more clearly illustrate the technical solutions in the embodiments or the prior art of the present application, the drawings used in the description of the embodiments or the prior art will be briefly described below.
FIG. 1 is the effect of ginger extract on NO secretion by RAW264.7 cells;
FIG. 2 is the effect of ginger extract on IL-6 secretion from RAW264.7 cells;
FIG. 3 is the effect of ginger extract on the expression of iNOS mRNA in RAW264.7 cells;
FIG. 4 effect of ginger extract on IL-6mRNA expression in RAW264.7 cells.
Detailed Description
Embodiments of the present application will be described in detail below with reference to examples, but those skilled in the art will appreciate that the following examples are only illustrative of the present application and should not be construed as limiting the scope of the present application. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
The following is a detailed description of the preparation method of ginger extract according to the embodiments of the present application:
currently, 6-gingerol is known as the main active ingredient in ginger extract, and the structure of the active ingredient is shown in the following formula 1.
Figure BDA0002359001210000031
Specifically, the inventors found that 6-gingerol is unstable when heated, and that the active ingredient present as gingerol has β -hydroxy ketone group structure in the molecular structure of 6-gingerol, and that heat can remove one molecule of water to form the corresponding shogaols, as shown in formula 2.
Figure BDA0002359001210000032
Therefore, the inventor believes that if the main active ingredient (6-gingerol) in ginger extract can be converted into a more active ingredient by a certain technique, the ginger extract will have the effect of being used with half the effort in anti-inflammatory applications.
As previously mentioned, 6-gingerol is thermally unstable and is susceptible to structural changes by heat, thereby altering biological activity. However, it is necessary to carefully examine how to heat it, and particularly, the heating mode in the extraction process needs to be properly selected. The following describes a method for preparing ginger extract in the examples of the present application.
In an example, the method of preparing ginger extract of the present application comprises: dried ginger powder is provided in which fresh ginger is heated to be dried at a temperature of 60 ℃ to 90 ℃ (the water content of the dried ginger powder may be limited to 0 to 5 wt%). Extracting the dried ginger powder for 3 to 5 times with the material-liquid ratio of 1:1g/mL to 1:40g/mL for 30 to 60 minutes each time by using ethanol or ethanol with the volume content of more than 50% as an extracting agent, and combining the extracting agents after three times of extraction to obtain an extracting solution. Removing ethanol from the extractive solution by vacuum distillation, and freeze drying to obtain solid.
The ginger extract having improved biological activity can be obtained by the above-mentioned operations. As mentioned above, the inventors believe that the particular choice of heating temperature and heating regime during the preparation of ginger extract will help to obtain an extract with stable and high bioactivity. Thus, heating prior to extraction of the ginger material is an option in the present application being an example. For example, dried ginger powder is obtained by pulverizing fresh ginger after heat-drying at 60 ℃ to 90 ℃ (e.g., 63 ℃, 74 ℃, 88 ℃, etc.).
For convenience of extraction, the ginger is further processed into ginger powder or ginger paste before drying. For example, after cleaning fresh ginger and treating scars, the ginger is cut into pieces by hand or broken by a beater. In addition, the dried ginger powder can be further crushed based on the requirement of convenient early-stage drying and subsequent leaching. In the example, the particle size of the further pulverized dried ginger powder is not larger than the mesh aperture of a 30-mesh sieve. Thus, the ginger is crushed in a relatively larger size and then dried, and then subjected to a relatively smaller size crushing operation. Thus, ginger is dried by heating in a relatively large size while maintaining the activity of the active material, and then extracted by refining particles in order to improve extraction efficiency.
Through the above operation, ginger is prepared in an easily extractable state and contains a high content of bioactive substance/target substance (6-shogaol). For a specific extraction method, extraction at normal temperature or extraction by heating may be employed. The extractant in the extraction process is selected from ethanol or its water solution.
For example, in the step of extracting the dried ginger powder, the temperature of the extract is from room temperature to 90 ℃ (e.g., 42 ℃, 46 ℃, 52 ℃, 58 ℃, 63 ℃, 69 ℃, 75 ℃ or 88 ℃). Under heating conditions, the method for extracting the dried ginger powder can be selected to include a reflux method or an ultrasonic method, and the power of the ultrasonic wave can be selected to be between 90W and 300W. Generally, the method of heat extraction is applicable to thermally stable substances. However, as previously mentioned, it is contemplated that 6-shogaol may be obtained by thermal conversion of 6-shogaol, and thus, the heating method will generally facilitate extraction of 6-shogaol.
Among them, the reflux method is, for example, a method of extracting a target substance using volatile ethanol or an aqueous solution thereof as an organic solvent. In the process, volatile components are condensed and repeatedly flow back to the leacher to extract medicinal materials. Repeating the steps until the reflux extraction of the effective components is complete. The method is suitable for extracting heat stable medicinal materials.
The ultrasonic extraction method benefits from the ultrasonic cavitation effect, and the sound impact flow and the impact wave generated by ultrasonic cavitation can cause local violent turbulence of a liquid system and high-speed collision of solid particles, so that a mass transfer boundary layer is thinned, and the mass transfer rate is increased.
The effect of ultrasonic extraction depends on the intensity and frequency of the extract, and is related to the tissue structure of the medicinal material, and the secondary effects of ultrasonic waves, such as mechanical vibration, emulsification, diffusion, crushing, chemical effect, etc., can also accelerate the diffusion release of the extract.
In order to obtain a high yield, avoid losses and at the same time increase the conversion, multiple extractions are carried out with a suitable increase in the time of each extraction. In the example, the dried ginger powder is extracted 3 to 5 times. The time of each extraction is selected to be 30 to 60 minutes (34 minutes, 37 minutes, 42 minutes, 46 minutes, 55 minutes or 59 minutes), and the extractants after three extractions are combined to obtain an extracting solution.
The extract may be filtered through a filter membrane to remove impurities. The extractant, which may comprise ethanol, or a mixture of ethanol and water, is then removed by appropriate steps. Wherein ethanol is evaporated by distillation under reduced pressure to remove ethanol, and water is removed by freeze drying. In an example, ethanol is removed from the extract, followed by removal of water.
The temperature in the process of removing ethanol in the extracting solution by reduced pressure distillation is 40-50 ℃, the pressure is 100-150Pa, and the time is 1-3 hours.
Freeze-drying is, for example, a drying method in which the extract is removed of ethanol, frozen to a temperature below the freezing point of water to convert the water into ice, and then the ice is removed by converting the ice into vapor under a relatively high vacuum. The conditions of the freeze-drying may be selectively adjusted according to the circumstances, for example, the degree of vacuum is limited to less than 10Pa, and the drying time is limited to, for example, 48 hours.
The ginger extract, which exists as a solid body and can be studied and used as a solution by dissolving in an organic solvent, can be obtained based on the implementation of the above-described scheme. And the extract showed anti-inflammatory effect under study.
The preparation of ginger extract of the present application is further described in detail with reference to the following examples.
Example 1
1. The preparation method of the extract comprises the following steps:
cutting fresh ginger into ginger powder, drying in an oven at 60 ℃, crushing the dried ginger, sieving with a 40-mesh sieve, adding 70% ethanol water solution according to the material-liquid ratio of 1:20, performing ultrasonic extraction for 30 minutes at normal temperature, repeatedly extracting for 3 times, distilling the obtained filtrate under reduced pressure to remove ethanol, and freeze-drying to obtain the ginger extract, wherein the ginger extract is recorded as 60G (the 6-shogaol content is 421.41 +/-62.91 mg/kg, and the recovery rate is 92.5 +/-12.35%).
Example 2
1. The preparation method of the extract comprises the following steps:
cutting fresh ginger into ginger powder, drying in an oven at 90 ℃, crushing the dried ginger, sieving by a 40-mesh sieve, adding 70% ethanol water solution according to the material-liquid ratio of 1:20, performing ultrasonic extraction for 30 minutes at normal temperature, repeatedly extracting for 3 times, distilling the obtained filtrate under reduced pressure to remove ethanol, and freeze-drying to obtain the ginger extract, wherein the ginger extract is recorded as 90G (the 6-shogaol content is 999.50 +/-173.64 mg/kg, and the recovery rate is 92.5 +/-12.35%).
Comparative example 1
1. The preparation method of the extract comprises the following steps:
cutting fresh rhizoma Zingiberis recens into powder, pulverizing, sieving with 40 mesh sieve, adding 70% ethanol water solution at a ratio of 1:20, performing ultrasonic extraction at room temperature for 30 min, repeatedly extracting for 3 times, distilling the filtrate under reduced pressure to remove ethanol, and freeze drying to obtain rhizoma Zingiberis recens extract (FG (6-shogaol content 11.67 + -1.08 mg/kg, recovery rate 92.5 + -12.35%).
Test example 1
In vitro anti-inflammatory assays.
(1) And (4) detecting the content of NO in the cell culture supernatant.
Mouse macrophage cells in logarithmic growth phase Raw264.7 were plated in 12-well plates and cultured for 24h, cells were incubated for 24h with 0.1. mu.g/mLLPS and 50mg/mL extract, cell supernatants were collected and quantified for NO production by the NO standard curve using Greiss reagent. The results are shown in FIG. 1, where 60G and 90G are better able to inhibit cellular NO production than FG.
(2) And (4) detecting the content of IL-6 in the cell culture supernatant.
Mouse macrophage cells in logarithmic growth phase Raw264.7 were plated in 12-well plates and cultured for 24h, cells were incubated for 24h with 0.1. mu.g/mLLPS and 50mg/mL extract, and cell supernatants were collected and assayed for IL-6 levels using ELISA kits. The results are shown in FIG. 2, where 60G and 90G are better able to inhibit the production of the cytokine IL-6 than FG.
(3) Inflammation-associated gene expression in cells.
Mouse macrophage Raw264.7 in logarithmic growth phase is plated in a 12-well plate and cultured for 24h, 0.1 mu g/mLLPS and 50mg/mL extract are added to incubate cells for 24h, RNA is collected and extracted from the cells, the RNA is reversely transcribed into cDNA, and the iNOS and IL-6mRNA expression level of the cells is detected by real-time quantitative PCR. The results are shown in FIGS. 3 and 4, where 60G and 90G are better able to inhibit cellular inflammation-associated mRNA expression than FG.
The above description is only a preferred embodiment of the present application and is not intended to limit the present application, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, improvement and the like made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims (8)

1. A method of preparing a ginger extract, comprising:
providing dry ginger powder obtained by heating fresh ginger to be completely dried at a temperature of 60-90 ℃, wherein the particle size of the dry ginger powder is below the aperture of a mesh of a 30-mesh screen;
extracting the dried ginger powder for 3 to 5 times under the condition of a material-liquid ratio of 1:1g/mL to 1:40g/mL by using ethanol or ethanol with the volume content of more than 50% as an extracting agent, wherein the extracting time is 30 to 60 minutes each time, and combining the extracting agents after three times of extraction to obtain an extracting solution;
removing ethanol from the extractive solution by distillation under reduced pressure, and freeze drying to obtain solid.
2. The method of claim 1, wherein the dried ginger powder is obtained by pulverizing fresh ginger after drying the ginger under heating at a temperature of 60 ℃ to 90 ℃.
3. The method of preparing a ginger extract according to claim 1, wherein the fresh ginger is further processed into bruised ginger or mashed ginger prior to drying.
4. The method of claim 1, wherein the dried ginger powder has a particle size of less than or equal to a mesh aperture of a 30 mesh screen.
5. The method of claim 1, wherein the step of extracting the dried ginger powder comprises extracting the dried ginger powder at a temperature of room temperature to 90 ℃.
6. The method of claim 5, wherein the extraction of the dried ginger powder is performed by a reflux method or an ultrasonic method.
7. The method as claimed in claim 1, wherein the temperature of the process of removing ethanol from the extractive solution by distillation under reduced pressure is 40-50 ℃, the pressure is 100-150Pa, and the time is 1-3 hours.
8. A ginger extract obtained by the method for producing a ginger extract according to any one of claims 1 to 7.
CN202010017118.0A 2020-01-08 2020-01-08 Ginger extract with anti-inflammatory activity and preparation method thereof Pending CN111012893A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010017118.0A CN111012893A (en) 2020-01-08 2020-01-08 Ginger extract with anti-inflammatory activity and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010017118.0A CN111012893A (en) 2020-01-08 2020-01-08 Ginger extract with anti-inflammatory activity and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111012893A true CN111012893A (en) 2020-04-17

Family

ID=70198539

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010017118.0A Pending CN111012893A (en) 2020-01-08 2020-01-08 Ginger extract with anti-inflammatory activity and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111012893A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111671740A (en) * 2020-07-28 2020-09-18 中国农业科学院农业质量标准与检测技术研究所 Application of 6-shogaol in preparation of medicine for inhibiting liver injury caused by endotoxin and medicine for inhibiting liver injury caused by endotoxin

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102845754A (en) * 2012-09-18 2013-01-02 贵州博方民族药业开发有限公司 Ginger extract and preparation method thereof
CN103432562A (en) * 2013-09-12 2013-12-11 南京泽朗农业发展有限公司 Method for extracting fresh ginger polyphenol from fresh ginger
CN107441463A (en) * 2017-07-06 2017-12-08 成都市中草药研究所(成都市卫生计生药械科技服务中心) A kind of ginger concocting method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102845754A (en) * 2012-09-18 2013-01-02 贵州博方民族药业开发有限公司 Ginger extract and preparation method thereof
CN103432562A (en) * 2013-09-12 2013-12-11 南京泽朗农业发展有限公司 Method for extracting fresh ginger polyphenol from fresh ginger
CN107441463A (en) * 2017-07-06 2017-12-08 成都市中草药研究所(成都市卫生计生药械科技服务中心) A kind of ginger concocting method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MIN-HSIUNG PAN: "《6-Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and cox-2 in murine macrophages》", 《MOLECULAR NUTRITION & FOOD RESEARCH》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111671740A (en) * 2020-07-28 2020-09-18 中国农业科学院农业质量标准与检测技术研究所 Application of 6-shogaol in preparation of medicine for inhibiting liver injury caused by endotoxin and medicine for inhibiting liver injury caused by endotoxin

Similar Documents

Publication Publication Date Title
JP5795444B2 (en) Polysaccharide extraction method of higher plants and fungi based on microwave chemical treatment
CN101492483B (en) Method for extraction and purification of cordycepin, and method for preparation of cordycepin dry powder
JP2016028104A (en) Picrorhiza kurroa extract for prevention, elimination and treatment of dna viruses in humans and in biotechnology industry
CN111012893A (en) Ginger extract with anti-inflammatory activity and preparation method thereof
CN111040046A (en) Efficient preparation method of sparassis crispa polysaccharide
CN101328201A (en) Method for extracting betulin from birch bark
CN110698524B (en) Method for extracting paeoniflorin from peony seed meal by microwave combined pulsed electric field
CN114424824A (en) Ampelopsis grossedentata extract, preparation method thereof and application thereof in preparation of lipid-lowering and liver-protecting medicines or foods
CN103204895B (en) A kind of method of separating ursolic acid from Pericarpium Mali pumilae
CN1288162C (en) Process for extraction refining amygdalin
WO2019184025A1 (en) Method for preparing polyarabogalacturonic acid by using dried tangerine peel
RU2712094C1 (en) Method of producing purified inulin from vegetable raw material
CN107904023B (en) Method for extracting residual grease from degreased dried shrimp residues of Antarctic krill
CN111196796A (en) A method for extracting quercetin from herba Taxilli
CN115463181B (en) Preparation method of agilawood leaf extract
Uttara et al. Microwave assisted extraction of crude drugs
CN106699915A (en) Method for improving dissolution rate of polysaccharide of grapeseed extract through pressure-shear induced chemical transition
CN110724593A (en) Method for extracting volatile oil from artemisia scoparia
CN112023442A (en) Preparation method and application of allspice extract
CN115040443B (en) Preparation method of Alsophila spinulosa leaf extract
CN108752393A (en) A kind of extracting method of cigarette natural polyphenol and flavonoids
RU2346941C2 (en) Method of dihydroquercetin extraction from larch wood, and device for method implementation
CN103183615B (en) A kind of extracting method of honeysuckle chlorogenic acid and goods thereof
CN106632206A (en) Method for improving dissolubility of proanthocyanidins of grape seed extract in press-shear assisted interaction manner
KR102670020B1 (en) METHOD FOR EXTRACTION GINSENOSIDE COMPOUND k

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200417